Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This trial is a phase II, multi-center, single-masked (assessors) dose-ranging study designed
to evaluate the comparative safety and preliminary efficacy of two dosage regimens of the
IBE-814 IVT Dexamethasone Implant in patients with DMO and RVO.